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C1, interoceptive/DMN network; C2, cortico-striatal-thalamic network; C3, basal ganglial 
network; C4, salience network; SD7, after seven days of stimulation; SD14, after 14 days of daily 
stimulation; PSD7, seven days post-stimulation cessation; PSD14, 14 days post-stimulation 
cessation; and PSD20, 20 days post-stimulation cessation.  
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Background: Evidence suggests that repetitive transcranial magnetic stimulation (rTMS), a non-
invasive neuromodulation technique, alters resting brain activity. Despite anecdotal evidence 
that rTMS effects wear off, there are no reports of longitudinal studies, even in humans, 
mapping the therapeutic duration of rTMS effects. 
Objective: Here, we investigated the longitudinal effects of repeated low-intensity rTMS (LI-
rTMS) on healthy rodent resting-state networks (RSNs) using resting-state functional MRI (rs-
fMRI) and on sensorimotor cortical neurometabolite levels using proton magnetic resonance 
spectroscopy (MRS).  
Methods: Sprague-Dawley rats received 10 min LI-rTMS daily for 15 days (10 Hz or 1 Hz 
stimulation, n=9 per group). MRI data were acquired at baseline, after seven days and after 14 
days of daily stimulation and at two more timepoints up to three weeks post-cessation of daily 
stimulation. 
Results: 10 Hz stimulation increased RSN connectivity and GABA, glutamine, and glutamate 
levels. 1 Hz stimulation had opposite but subtler effects, resulting in decreased RSN 
connectivity and glutamine levels. The induced changes decreased to baseline levels within 
seven days following stimulation cessation in the 10 Hz group but were sustained for at least 14 
days in the 1 Hz group.  
Conclusion: Overall, our study provides evidence of long-term frequency-specific effects of LI-
rTMS. Additionally, the transient connectivity changes following 10 Hz stimulation suggest that 
current treatment protocols involving this frequency may require ongoing “top-up” stimulation 
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Introduction 
Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive neuromodulation 
technique widely applied in therapeutic and investigative studies of neuropsychiatric conditions 
including depression [1, 2], schizophrenia [3], and Parkinson’s disease [4]. Despite increasing 
use of rTMS to modulate dysfunctional brain networks in humans, the mechanisms underlying 
its therapeutic effects, particularly in cortical circuits, still require elucidation. Furthermore, 
patients report that therapeutic benefits of rTMS wear off after treatment finishes [e.g., 5, 6], 
suggesting an urgent need to characterise the persistence of rTMS effects. 
Therapeutic rTMS application utilises different stimulation frequencies to elicit different cortical 
changes: low-frequency (< 5 Hz) stimulation has inhibitory and high-frequency (> 5 Hz) has 
excitatory effects on the cortex, albeit with some individual variability [7, 8]. Preclinical models 
have identified gene and protein expression changes associated with these frequency-specific 
changes in excitatory and inhibitory circuit activity [9-12]. In addition, changes in 
neurotransmitters Glutamate (Glu), γ-aminobutyric acid (GABA), and glutamine (Gln), the major 
precursor for neuronal glutamate and GABA [13], are central to excitability changes observed 
following stimulation [9, 14, 15]. High-frequency stimulation increases excitatory neuronal 
activity [16, 17] and induces a long-lasting increase in glutamatergic synaptic strength 
consistent with long-term potentiation (LTP) of excitatory circuits [9], while simultaneously 

















inhibitory circuit activity by increasing GABA levels [19] and modulates expression of calcium-
binding proteins in inhibitory interneurons [10, 12].  
Although animal models have revealed some key mechanisms of rTMS, in most preclinical 
studies, changes in the brain are investigated post-mortem, providing only a snapshot of rTMS-
induced changes. Additionally, most animal and human studies focus on events occurring 
minutes to hours after single or multiple stimulations. Consequently, the development of rTMS 
effects over time, and the stability of its after-effects, have not been explored. 
Non-invasive magnetic resonance (MR) based techniques are ideal for longitudinal studies of 
brain function and neuroplasticity [20]. Resting-state functional magnetic resonance imaging 
(rs-fMRI) is the technique of choice for examining long-term changes in functional networks 
[21-25], while proton (1H) magnetic resonance spectroscopy (MRS) is one of only few methods 
that can non-invasively assay neurometabolic changes. Rs-fMRI identifies brain regions showing 
synchronised resting activity which form organised networks called resting-state networks 
(RSNs) [26]. RSN dysregulations, and accompanying neurometabolic changes, have been 
identified in patients with neuropsychiatric disorders [27], e.g., schizophrenia and depression 
[28]. Both RSN functional connectivity (FC) and neurometabolite levels in humans are sensitive 
to rTMS and clinical improvements are associated with changes in RSNs [for review, see 25]. 
However, there have been no reports of longitudinal studies to characterise the timecourse of 
changes in RSNs or neurometabolites during and after rTMS treatment.  
A single session of low-intensity rTMS (LI-rTMS) in rats has frequency-specific effects on RSNs 

















suggests that LI-rTMS in rodents can be a useful model in a translational pipeline to inform and 
guide clinical application of rTMS, particularly given the cost and logistical challenges of 
longitudinal human studies. For example, recent active fMRI/rTMS studies in animal models of 
traumatic brain injury have shown that repeated delivery of high-frequency rTMS increased 
primary somatosensory activity in response to forelimb stimulation, indicating restored cortical 
function [29, 30]. The present study used rs-fMRI and MRS in rats to investigate the emergence 
of LI-rTMS-induced changes in FC and neurometabolite levels respectively and their 
maintenance for up to three weeks. Two weeks of daily stimulation resulted in significant 
changes in FC and neurometabolites that outlasted the duration of stimulation. A better 
understanding of rTMS effects on RSNs and neurometabolites may prove helpful in the 
development of long-lasting treatment options to modify dysfunctional connectivity detected in 

















Materials and Methods 
Animals 
Experimental procedures were approved by the UWA Animal Ethics Committee 
(RA/3/100/1430) in accordance with the Australian code for the care and use of animals for 
scientific purposes. 18 adult male Sprague-Dawley rats (6-8 weeks old, 150-250g) from the 
Animal Resources Centre (Canning Vale, Western Australia) were maintained in a temperature-
controlled animal care facility on a 12-hour light-dark cycle with food and water ad libitum. 
Animals were euthanised after the last imaging session using CO2 asphyxiation. 
Experimental Protocol 
Following acquisition of baseline rs-fMRI data, all animals received daily 10 min LI-rTMS at 10 Hz 
or 1 Hz for 15 days (n=9/group, Fig. 1). LI-rTMS was delivered using a custom-built round coil 
[described in detail in 21, 31] held by the experimenter between right eye and ear (~13 mT at 
cortical surface). Animals were habituated to handling and to the coil for one week, as 
described previously [11, 32]. Imaging was conducted under isoflurane-medetomidine 
combination anaesthesia weekly during stimulation. Another two imaging sessions were 
performed seven and 20 days after stimulation was ceased for the 10 Hz group, and seven and 
14 days after stimulation was ceased for the 1 Hz group. The only difference between the 
imaging timeline of the two groups was the timing of the last imaging session (20 days after 
stimulation cessation for the 10 Hz group and 14 days after stimulation cessation in the 1 Hz 

















scanning procedure, medetomidine was antagonised by an injection of atipamezole. See 
supplementary methods for further details, drug dosing, etc. 
Data acquisition 
All MR images were acquired with a 9.4 T Bruker Biospec 94/30 small animal MRI using the 
imaging protocol as described in the supplementary methods and in [21]. Briefly, the 
acquisition protocol included the following sequences: 1) multi-slice 2D RARE (rapid acquisition 
with relaxation enhancement) sequence for three T2-weighted scans (TR=2500ms, TE=33ms, 
matrix=280x280, 21 coronal and axial slices, 20 sagittal slices, thickness=1mm); 2) single-shot 
gradient echo EPI (TR=1500ms, TE=11ms, matrix=94x70, 21 coronal slices, thickness=1mm, pixel 
size=0.3x0.3mm2, flip angle=90°, 300 volumes) for resting-state; and 3) point-resolved 
spectroscopy (PRESS) sequence with one 90° and two 180° pulses, and water suppression for 
1H-MRS (TE=16 ms, TR=2500 ms) with 64 averages (Table A.1) with a 3.5x2×6mm3 voxel placed 
over the right sensorimotor cortex (Fig. 2). 
Image processing and analysis 
Image processing was performed as described in Seewoo et al. [21], with the following changes: 
1) qimask utility from QUIT (QUantitative Imaging Tools) used for skull-stripping [33]; 2) 
Gaussian kernel filter was set to a full-width half maximum of 6.25mm for single-session 
independent component analysis (ICA); and 3) FIX (FMRIB's ICA-based Xnoiseifier v1.06; 
threshold 20) was trained to automatically remove noise components (See Supplementary 

















Because of the exploratory nature of this study, an ICA-based approach was used to identify 
whole-brain FC changes. Multi-subject temporal concatenation group-ICA was carried out on 
baseline rs-fMRI data using MELODIC to identify template RSNs (Fig. 3). The ICA algorithm was 
restricted to 15 components based on other rs-fMRI studies in rodents [21, 36, 37]. Dual 
regression analysis was then conducted on relevant RSNs for between-timepoint comparisons 
[38, 39], controlling for family-wise error (FWE) and using a threshold-free cluster enhanced 
(TFCE) technique to control for multiple comparisons (P < 0.05). Regions showing significant 
differences (Fig. 4-5) were then labelled using a rat brain atlas [40].  
MRS data analysis and presentation 
MRS data was analysed in LCModel (“Linear Combination of Model spectra” version 6.3-1L) [41] 
using a set of simulated basis set provided by the software vendor. Individual metabolite 
concentrations were computed using the unsuppressed reference water signal for each 
individual scan. The Cramér-Rao lower bounds (CRLBs) were calculated by LCModel and 
reported as the percentage of the estimated concentrations to determine reliability of the 
metabolite estimates (see Table A.2 for quantification details). The metabolites of interest were 
GABA and Glu, the major neurotransmitters in the brain, Gln, a neurotransmitter precursor, and 
combined glutamate-glutamine (Glx). All results presented for the metabolite concentrations 
are expressed as Tau ratios (metabolite concentration/Tau concentration) because (i) Tau peak 
could be identified with high reliability by LCModel (CRLB < 10%), and (ii) to the best of our 
knowledge, there is no literature showing high (HI) or low intensity rTMS-related changes in 
Tau. To improve sensitivity for detecting changes in glutamate-glutamine cycle function, we 

















neurotransmission. Analyses and plots of metabolites ratios were carried out using RStudio 
version 3.5.2 [http://www.rstudio.com/42]. Three data points from each group were excluded 
from the analyses due to identification as outliers by boxplots, bad shimming and/or bad voxel 
positioning leading to high CRLB values. Repeated-measures ANOVA (‘lme4’ and ‘lmerTest’ 
packages) was utilised to test for between-timepoint differences. When significant main effects 
of timepoints were found, post hoc pairwise differences were calculated (‘glht’ in ‘multcomp’ 
package) to determine significant changes in metabolite ratios between two timepoints (Fig. 6). 



















Template RSNs identified by group-ICA 
Template rodent RSNs were identified from baseline data to avoid including LI-rTMS-related 
RSN alterations in the template components and thus increase the sensitivity of dual regression 
in detecting between-group differences [39]. Based on visual inspection of the 15 components 
identified by group-ICA, four components (Fig. 3) were identified as classical rodent RSNs [e.g., 
37, 43, 44, 45]. The remaining eleven components were classified as noise (see examples in Fig. 
A.1). Component 1 is dominated by a cortical ribbon, and interoceptive [44] and default mode 
network (DMN) [46] structures (Table 1) are grouped to form a network. Component 2 (cortico-
striatal-thalamic network) includes similar structures as C1 (see Table 1 for differences). A 
similar network was identified by [43] in infant rats, without the high correlation in the cortex 
seen in C2 but with a greater correlation to the hippocampus. Component 3 (basal ganglial 
network) mostly involves subcortical regions (Table 1), similar to the network reported in infant 
rats by Bajic et al. [43]. Component 4 presents characteristics of the salience network, showing 
specific overlap with the insular and somatosensory cortices [43]. 
Functional connectivity changes 
Rs-fMRI data was acquired at five timepoints: baseline, after seven stimulation sessions (SD7), 
after 14 stimulation sessions (SD14), seven days after stimulation cessation (PSD7), and either 
20 days (10 Hz group) or 14 days (1 Hz group) after stimulation cessation (PSD20 or PSD14 

















potentiation of FC in C1, C2, and C3 (Fig. 4) while 1 Hz LI-rTMS significantly attenuated FC in C2, 
C3, and C4 (Fig. 5). 
Daily 10 Hz stimulation significantly increased FC of several brain regions to C1 by SD7 (Fig. 4A) 
and this increase was even greater on SD14. Following stimulation cessation, C1 FC decreased 
back to baseline levels over 20 days, with the drop being more significant and widespread on 
PSD20 than on PSD7. There were no significant differences between PSD7 and PSD20 or 
between baseline and both PSD7 and PSD20, showing that FC returned to baseline within one 
week after stimulation was stopped. C2 FC was unchanged on SD7 but significantly increased by 
SD14 (Fig. 4B). FC returned to and remained stable at baseline by PSD7. Similarly, C3 FC to the 
left somatosensory cortex, striatum and dorsal hippocampus peaked at SD14 (Fig. 4C) and 
decreased back to baseline by PDS7. Surprisingly, C3 FC on SD14 was also found to be 
significantly reduced in the right striatum, insular cortex, bilateral ventral hippocampus, 
thalamus, and auditory cortex, returning to baseline by PSD7 as well (see more detailed 
changes in Table A.3). 
In the 1 Hz group, C2 FC to the left somatosensory significantly dropped after 14 stimulation 
sessions (Fig. 5A). C2 FC to the right thalamus and left striatum was elevated on PSD14 
compared to SD14 despite there being no significant changes in these regions compared to 
baseline at both timepoints. Additionally, there was a significant decrease C3 FC on SD14 (Fig. 
5B) that was sustained on PSD7 but had returned to baseline by PSD14. In contrast, the 
decreased C4 FC to the right somatosensory cortex noted on SD14 stayed below baseline on 


















Changes in metabolite ratios 
To gain further insight into the association between FC and neurometabolic changes, we 
measured Gln, Glu, Glx and GABA levels in the sensorimotor cortex using 1H-MRS. Please note 
that herein we have chosen to report the MRS data as metabolite ratios relative to Tau, for the 
following reasons. Typically, in-vivo 1H-MRS studies report metabolite concentrations in a 
relative manner using an internal concentration reference: water or any specific metabolite [47, 
48]. The use of water as reference signal requires several uncertain corrections, for example 
due to partial volume and relaxation effects [49]. Moreover, the water concentration in brain 
tissue has to be determined because water signal arises from a combination of brain tissue and 
cerebrospinal fluid while detectable metabolites are exclusively found in brain tissue [50, 51]. 
Metabolite concentration ratios, as reported in this study, are less sensitive to these effects. 
The choice of the metabolite reference is arbitrary unless the metabolite concentration is 
expected to vary between groups and timepoints [48]. To our knowledge, there is no literature 
showing rTMS-related changes in Tau, and accordingly we have chosen Tau as a concentration 
reference in our study (see Table A.5 for water-referenced metabolite concentrations in 
institutional units). 
Spectra obtained were reproducible longitudinally (see example in Fig. A.2). Unpaired Welch 
Two Sample t-test showed no significant differences in the baseline metabolite/Tau ratios 
between 10 Hz and 1 Hz groups.  
Following 10 Hz stimulation, repeated-measures ANOVA revealed a main effect of timepoint for 
all five metabolite ratios investigated (Table 2). Post hoc comparisons showed a significant 

















increased non-significantly (see Table A.4 for mean metabolite concentrations). The levels of all 
four metabolites returned to baseline after an additional seven days of stimulation (i.e., no 
significant difference between baseline and SD14). After cessation of stimulation, Gln and Glx 
levels on PSD7 and PSD20 were significantly lower than on SD7. In contrast, Glu and GABA 
levels were only significantly lower than SD7 on PSD20. On the other hand, Glu/Gln levels 
decreased non-significantly from baseline with daily stimulation and increased significantly 
between SD7 and PSD7, and between SD14 and PSD7. There was a significant drop in Glu/Gln 
level on PSD20 compared to PSD7, i.e., Glu/Gln level decreased back to baseline by PSD20. 
For the 1 Hz group, repeated-measures ANOVA did not detect significant timepoint-related 
changes in any metabolite (P < 0.1 for Gln, Glu and Glx; and P > 0.1 for GABA and Glu/Gln). Gln 
(P = 0.0873), Glu (P = 0.0444) and Glx (P = 0.0229) levels decreased to lower than baseline on 
PSD7, after cessation of stimulation (Fig. 6). 
Discussion 
rTMS therapy is normally delivered to patients as a course of treatment over several weeks to 
induce lasting plastic changes. However, the stability of these changes remains unknown. This 
study examined both the emergence and maintenance of changes in FC and neurometabolite 
levels, assessed with rs-fMRI and MRS respectively, following repeated LI-rTMS in rats. Our 
study confirms the frequency-specific effects of LI-rTMS and further suggests that effects of 1 
Hz stimulation, although milder, may persist for longer after cessation of treatment than the 
effects of 10 Hz stimulation. We discuss the longitudinal FC changes observed here in rats in the 

















Although to directly extrapolate findings from healthy naïve rats to patients may be tenuous at 
this early stage of investigation, our findings support the existing use of weekly maintenance 
treatments in 10 Hz treatment of depression [see review, 52].   
Functional connectivity changes in 10 Hz group 
In line with previous studies showing increased excitability and induction of LTP following high-
frequency rTMS, we found that daily 10 Hz LI-rTMS potentiated FC in the C1, C2 and C3 
networks. Our results of increased FC in C1 and C2 are in agreement with findings from 
previous human studies reporting that rTMS increased FC of the DMN in patients with multiple 
system atrophy [53] and also of the cortico-striatal-thalamic network in patients with stroke 
[54] and in maladaptive emotion regulation [55-57]. Additionally, our finding of increased C3 FC 
to the left hippocampus, somatosensory cortex and striatum is comparable to the increased FC 
detected between the stimulated parietal cortex and the hippocampus following 20Hz rTMS in 
healthy adults [58] and the increased activity of the stimulated somatosensory cortex and the 
basal ganglia following 5 Hz rTMS in patients with focal dystonia [59], although the increased FC 
observed here is in the contralateral hemisphere. 
Interestingly, within C3 we also found decreased FC in several regions, which is in contrast with 
previous reports of increased activity in the temporal cortex and hippocampus after two 
sessions of 20Hz rTMS in humans [60]. However, the decrease in C3 FC to some brain regions is 
potentially due to a change in their resting activity making them more synchronous to other 
components and therefore less synchronous to C3. There is considerable overlap in the brain 

















C1 FC to the left thalamus (z=40-41), increase in C2 FC to the right thalamus (z=33-34), and 
increase in C2 FC to the right striatum (y=84-86). 
In contrast to the significant changes observed after one day [21] and after 15 days of 
stimulation, FC within all networks after stimulation cessation was not significantly different 
from baseline. However, changes in FC compared to SD14 were more widespread and 
significant on PSD20 than on PSD7, showing that the change in FC observed on SD14 compared 
to baseline decreased gradually, back to baseline, after daily stimulation was stopped. Our 
finding is relevant in refining an optimal strategy for maintenance treatments, particularly for 
depression in which 10 Hz stimulation is an approved treatment regime (although iTBS has 
recently also been approved [61, 62]). Most studies of rTMS treatment for depression focus on 
immediate and long-term effects, with only a few behavioural studies investigating the efficacy 
of “top-up” or maintenance rTMS delivery to prevent relapse [e.g., 5, 63-65]. However, because 
these are performed in patients, there is considerable variation within such studies and 
establishing a reliable protocol is difficult. Our studies suggest that weekly maintenance 
stimulation delivery may be appropriate, but future studies should investigate if an optimal 
time can be identified for delivering “top-up” rTMS to maintain FC changes in humans.  
Functional connectivity changes in 1 Hz group 
Overall, 1 Hz stimulation had less widespread effects on FC than 10 Hz stimulation, which was 
also observed in our previous study looking at the immediate effects of one 10 min LI-rTMS 
session [21]. Additionally, in the present study, daily 1 Hz stimulation mostly attenuated FC. The 

















observed in previous studies [see review 66]; induction of rTMS-related changes is known to be 
less likely with low- than high-frequency rTMS, and when changes are induced, the effect-
direction is negative following low-frequency rTMS and more frequently positive following high-
frequency rTMS.  
There was a significant decrease in C2 FC to the left and C4 FC to the right somatosensory 
cortex on SD14. Similarly, a bilateral decrease in activity in somatosensory cortex following 1 Hz 
rTMS in healthy volunteers was observed by Min et al. [67]. However, in contrast to our 
findings, they observed more prominent and longer-lasting changes in the contralateral 
compared to the ipsilateral somatosensory cortex. Nevertheless, this difference might be 
related to the state dependency of rTMS effects [e.g., reported in 68] as Min and colleagues 
[67] used a finger-tapping task instead of resting-state. Other rTMS studies have reported 
exclusively ipsilateral effects of 1Hz stimulation on the somatosensory cortex [69, 70], but have 
used different stimulation and detection methodologies, making comparisons difficult.  
Additionally, we observed a significant decrease in FC of the prelimbic cortex (homologous to 
human medial prefrontal cortex) to the basal ganglial network (C3), consistent with human 
literature showing attenuated FC between these two regions in healthy individuals following 1 
Hz stimulation [71]. Similarly, in patients with depression, 1 Hz rTMS has been shown to 
decrease activity in the prefrontal cortex and the basal ganglia while 10 Hz rTMS, most often 
used to alter aberrant connectivity in depression [see review 72], increased activity within these 
regions [73, 74]. Surprisingly, both frequencies are reported to have similarly beneficial 
outcomes in patients, with about half of the participants in each group responding to treatment 

















from the other [73]. This might be explained by the observation that patients can exhibit either 
hypoconnectivity between the ventromedial prefrontal cortex and ventral striatum, or 
hyperconnectivity between the dorsal prefrontal cortex and dorsal caudate [76]. Therefore, 
pre-treatment FC within this network might play an important role in patients’ antidepressant 
response to 1 Hz and 10 Hz rTMS [77]. 
Upon cessation of stimulation, C2 FC increased back to baseline, whereas the decrease in FC 
was sustained on PSD7 within C3 and even on PSD14 within C4. The continuous decrease in C4 
FC following stimulation cessation is surprisingly strong and may be related to either a decrease 
in excitatory circuits or an increase in inhibitory mechanisms. Previous animal studies have 
consistently shown increases in inhibitory circuit function a few hours after 1 Hz stimulation, 
but there are few studies that measure changes occurring days or weeks after stimulation. One 
study in rats demonstrated increasing expression of cortical markers of inhibitory 
neurotransmission over seven days after a single 70 min 1 Hz stimulation [78]. Taken together, 
our findings of decreased C2, C3 and C4 FC suggest that 1 Hz stimulation may have a sustained 
effect on the RSN by increasing inhibitory neurotransmission. LI-rTMS at 1 Hz may therefore be 
a useful tool for inducing long-term changes in brain function and warrants further 
investigation. 
Changes in neurometabolite concentrations induced by 10 Hz and 1 Hz 
stimulation 
Similar to our FC results, 10 Hz stimulation resulted in significant changes in neurometabolite 

















also suggested that repeated 1 Hz stimulation has limited effects on cortical markers of 
neuroplasticity [79] and induces only non-significant decreases in gene expression in the cortex 
[80]. We are cognisant that the difference in effect size and persistence of 10 Hz and 1 Hz LI-
rTMS might be related to differences in the total number of pulses applied (6,000 vs 600 pulses 
respectively) [81]. For example, a systematic study found that 600 pulses of 10 Hz stimulation 
had an excitatory effect but 1,200 pulses had no effect [81].  
To gain insight into the effect of LI-rTMS on excitatory and inhibitory networks within the 
sensorimotor cortex, we measured Gln and Glu, which have been positively correlated with 
various rTMS-measures of cortical excitability [9, 14, 15]. We also measured Glx (representing 
the sum of Gln+Glu) and Glu/Gln ratio to support the Gln and Glu data, as well as GABA, the 
main inhibitory neurotransmitter in the brain. Post hoc analyses revealed a significant but 
transient increase in Gln and non-significant increase in Glu, Glx and GABA following seven days 
(SD7) of 10 Hz stimulation. However, after an additional seven days of stimulation (SD14), levels 
of all four compounds returned to baseline. The noteworthy drop in metabolite levels observed 
on SD14 appears contradictory to the maintained increase in FC shown by our rs-fMRI data at 
this time point. A possible explanation is that the increased excitability induced by 10 Hz LI-
rTMS triggers homeostatic and/or metaplastic mechanisms to maintain a balance of 
excitation/inhibition in the brain [82, 83] (previously shown in neuronal cultures [84] and in rats 
[78, 85]), but without disrupting the increases in FC. Also, the MRS data reflect changes in the 
sensorimotor cortex only while FC changes were found in other brain regions as well. 
Nonetheless, the engagement of homeostatic control by 10 Hz LI-rTMS is consistent with the 

















longer detected a week after stimulation cessation. The implication is that 10 Hz may initially 
induce stronger effects in neural circuits than 1 Hz, but as a result, recruits compensatory 
mechanisms which limit the duration of LI-rTMS effects. By contrast, 1 Hz, which has more 
subtle effects on FC and neurometabolites, elicits more persistent effects with a sustained 
decrease in cortical Gln, Glu and Glx seven days after cessation of stimulation (PSD7) and 
changes in FC compared to baseline in the C4 network persisting up to the last timepoint 
studied (PSD14). 
Interestingly, the persistent decrease in GABA levels after cessation of 10 Hz stimulation, 
despite a lack of change in FC, is also consistent with a long-term facilitatory effect of 10 Hz 
stimulation acting via depression of GABAergic neurotransmission [see review 86]. Given that 
inhibitory interneurons control the activity and excitability of cortical principal neurons [87], 
previous studies have suggested that depression of inhibitory neurotransmission, as seen here, 
could facilitate associative plasticity (e.g., for improving learning and memory) in cortical 
networks [86]. This makes rTMS an attractive therapeutic intervention for several 
neuropsychiatric conditions associated with changes in inhibitory synaptic plasticity and 
excitation/inhibition-balance leading to behavioural and cognitive dysfunction [88], for example 
in schizophrenia [89, 90] and autism [91].  
The results of previous human MRS/rTMS studies are generally consistent with our findings, 
although use of healthy animals, the different number of stimulation sessions, as well as 
differences in intensity and frequency, preclude a direct comparison. Long-term (days to weeks) 
high-frequency rTMS to the prefrontal cortex increased cortical Gln and Glu levels in healthy 

















Interestingly, experiments in humans focussing on immediate effects rTMS detect a reduction 
in inhibitory synaptic interactions following high-frequency rTMS using motor evoked potentials 
(MEP) and paired-pulse protocols [reviewed in 96]. More recently, combined TMS paired-pulse 
and MRS studies show that the amount of intracortical inhibition does not correlate with the 
global levels of GABA in the primary motor cortex but may instead be linked to cortical 
glutamate levels [97]. Taken together, studies in humans and in rodents concur that rTMS 
induces complex changes in inhibitory and excitatory circuits that evolve over time and may 
involve frequency-specific effects on different cell types [reviewed in 98]. Our findings suggest 
that LI-rTMS in rodents induces changes that clearly reflect those occurring in humans following 
rTMS, and therefore provide a unique opportunity to combine non-invasive and invasive 
methods in the investigation of rTMS effects on neural circuitry.  
Nevertheless, this is the first exploratory study of longitudinal effects of repeated LI-rTMS on 
rodent neurometabolites, and researchers interested in, for example, more subtle effects 
should consider dedicating more time to collect spectra with higher SNR. This may reduce the 
observed variability of some low concentration metabolites such as GABA and Gln. Additionally, 
researchers interested in effects of rTMS on GABA could consider using MEGA-PRESS [99] or 



















Information about the duration of the after-effects of rTMS therapy is vital for the development 
and improvement of rTMS use as a treatment in a clinical setting. Here, we present the first 
longitudinal rs-fMRI/MRS investigation of the duration of FC and neurometabolic changes 
induced by repeated LI-rTMS delivery. Our work confirms the frequency-specific effects of LI-
rTMS and further suggests that effects of 1 Hz stimulation, although milder, may persist longer 
after cessation of treatment compared to those of 10 Hz stimulation. This study provides a 
framework to use non-invasive brain imaging to explore the duration of rTMS effects on resting 
brain activity in animal models of neurological and neuropsychiatric disorders such as 
depression for development and translation of optimised protocols to human patients. Further 
studies in animals and humans are warranted in effort to investigate potential prolongation of 
FC effects through maintenance or “top-up” rTMS sessions weeks or months after the first set 
of treatment.  
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Figure 1. Timeline of an experiment for one rat. A. The experiment consisted of an initial one-week 
period of habituation upon arrival of the animal, after which the rats had five sessions of MRI scans, each 
separated by at least one week. Day 0 was the first imaging session for acquiring baseline resting-state activity and 
neurometabolite levels. For the first two weeks, animals were stimulated daily for 10 min at 10 Hz (6,000 pulses) or 
1 Hz (600 pulses). Stimulation was ceased after 15 days of stimulation (after Day 14), but the animals were still 
imaged on Day 21 (all animals), Day 28 (1 Hz animals) and Day 34 (10 Hz animals). These five imaging timepoints 
will be referred to as: baseline, after seven (SD7) and 14 days (SD14) of daily stimulation and either 20 days (10 Hz 
group) or 14 days (1 Hz group) after stimulation cessation (PSD20 or PSD14 respectively). B. Protocol for a single 
scan session. During each session, the animal was under a combination of isoflurane and medetomidine 
anaesthesia throughout the experiment. Each session consisted of the acquisition of a localising scan, an 
anatomical scan, a B0 map, a localised shim, an MRS scan, whole brain shim, and an rs-fMRI scan. 
Figure 2. Volume of interest (VOI) positioning. The figure shows the position of the MRS voxel (size of 
3.5 mm × 2 mm × 6 mm) on the right sensorimotor cortex (ipsilateral to LI-rTMS delivery) on T2-weighted images 
for proton nuclear magnetic resonance spectroscopy. 
Figure 3. Template resting-state networks from baseline rs-fMRI scans. The figure illustrates 
coronal and corresponding axial slices of four RSNs (C1-C4) that were identified in the baseline rs-fMRI scans of 6-
7-week-old male Sprague Dawley rats under isoflurane-medetomidine combination anaesthesia. The four 
components were classified as follows: C1, interoceptive/DMN network; C2, cortico-striatal-thalamic network; C3, 
basal ganglial network; and C4, salience network. The spatial colour-coded z-maps of these components are 
overlaid on the rat brain atlas (down-sampled by a factor of eight) and the numbers on the bottom right corner of 
each slice refer to the position on the atlas. The RSN maps are represented as z-scores (n=22, thresholded at z > 3), 
with a higher z-score (yellow) representing a greater correlation between the time course of that voxel and the 

















include various brain regions: 1, striatum/caudate putamen; 2, somatosensory cortex; 3, thalamus; 4, 
hippocampus; 5, motor cortex; 6, auditory cortex; 7, retrosplenial cortex; 8, insular cortex; 9, cingulate cortex; 10, 
entorhinal cortex; 11, inferior colliculus; 12, association cortex. 
Figure 4. Functional connectivity changes within the (A) interoceptive/default mode network, 
(B) cortico-striatal-thalamic network and (C) basal ganglial network induced by 10 Hz LI-rTMS. 
The figure illustrates changes between five timepoints: baseline, after seven (SD7) and 14 days (SD14) of daily 
stimulation and after seven (PSD7) and 20 days (PSD20) post-stimulation cessation. The spatial colour-coded p-
value maps of these components are overlaid on the rat brain atlas (down-sampled by a factor of eight) and the 
numbers on the right refer to the slice position on the atlas. The dual regression maps are represented as p-values 
corrected for multiple comparisons at voxel level (n=9, thresholded at P < 0.05). R denotes right hemisphere. 
Significant differences were found in: 1, striatum/caudate putamen; 2, somatosensory cortex; 3, thalamus; 4, 
hippocampus; 5, motor cortex; 6, auditory cortex; 8, insular cortex; 9, cingulate cortex. 
Figure 5. Functional connectivity changes within the (A) cortico-striatal-thalamic network, (B) 
basal ganglial network and (C) the salience network induced by 1 Hz LI-rTMS. The figure 
illustrates changes between five timepoints: baseline, after seven (SD7) and 14 days (SD14) of daily stimulation and 
after seven (PSD7) and 14 days (PSD14) post-stimulation cessation. The spatial colour-coded p-value maps of these 
components are overlaid on the rat brain atlas (down-sampled by a factor of eight) and the numbers on the right 
refer to the slice position on the atlas. The dual regression maps are represented as p-values corrected for multiple 
comparisons at voxel level (n=9, thresholded at P < 0.05). R denotes right hemisphere. Significant differences were 
found in: 1, striatum/caudate putamen; 2, somatosensory cortex; 3, thalamus; 13, prelimbic cortex. 
Figure 6. Longitudinal changes in metabolite ratios at the different timepoints in rat 
sensorimotor cortex following 10 Hz and 1 Hz LI-rTMS. All graphs show mean ± standard error and post 

















follows: A, glutamine (Gln)/Tau ratio; B, glutamate (Glu)/Tau ratio; C, glutamine + glutamate (Glx)/Tau ratio; D, 













Table 1. Summary of brain regions within the four components identified by group-ICA. 
Components Networks Brain regions 
C1 Interoceptive/default 
mode network 
Cortical regions, e.g., the somatosensory cortex, 
motor cortex, auditory cortex, retrosplenial 
cortex, and cingulate cortex as well as the 
striatum and hippocampus. 
C2 Cortico-striatal-thalamic 
network 
Similar to C1, excluding the cingulate cortex but 
including the entorhinal cortex. Predominantly 
within the cortex, striatum, and thalamus. 
C3 Basal ganglial network Subcortical, mostly the striatum. 














Table 2. Summary of results from repeated-measures ANOVA of neurometabolite levels to 
test for main effect of timepoint. 
Group Metabolite F P 
10 Hz Gln/Tau 5.72 0.0016 ** 
 Glu/Tau 3.06 0.032 * 
 Glx/Tau 3.87 0.012 * 
 GABA/Tau 3.03 0.033 * 
 Glu/Gln 6.02 0.0012 ** 
1 Hz Gln/Tau 2.35 0.078 
†
 
 Glu/Tau 2.30 0.082 
†
 
 Glx/Tau 2.56 0.059 
†
 
 GABA/Tau 1.33 0.28 
 Glu/Gln 1.48 0.23 





















































































The duration of repeated LI-rTMS effects is described using rs-fMRI and MRS in rats. 
10 Hz effects were prominent during but not beyond the treatment period. 
10 Hz effects included transient increases in FC and glutamine levels in cortex. 
1 Hz decreased FC for up to 14 days after the treatment period. 
 
